BURLINGAME, Calif.--(BUSINESS WIRE)--Urigen Pharmaceuticals, Inc. (OTCBB: URGP, http://www.urigen.com), will give an Open House Podium Presentation at the 6th Annual BioPartnering North America Conference. The presentation will be held on February 5th at 11:45AM in the Fraser Room. Urigen’s President and Chief Executive Officer, William J. Garner, M.D. will provide a company overview, including discussion about Urigen’s two lead products: URG101 for Painful Bladder Syndrome, and URG201, an intra-nasal testosterone product for the treatment of male hypogonadism.
